Top Story

Summit Medical Group MD Anderson Cancer Center names chief of oncology

September 24, 2016

William T. DeRosa , DO, FACP, has been named chief of oncology services at Summit Medical Group MD Anderson Cancer Center.

Rosa will remain in clinical practice part time and also will serve on the Summit Medical Group Clinical Council.

In the Journals Plus

Minimal residual disease influences outcomes in relapsed, refractory ALL

September 23, 2016
Minimal residual disease negativity correlated with long-term survival in patients with relapsed and refractory acute lymphoblastic leukemia in first salvage, according…
Meeting News CoverageVideo

VIDEO: Thyroid imaging approaches not ‘one-size fits all’

September 23, 2016
DENVER — In this video exclusive, Megan R. Haymart, MD, assistant professor of medicine at the University of Michigan Medical School in Ann Arbor, discusses…
Meeting News Coverage

Combination therapy with venetoclax demonstrates activity in AML

September 23, 2016
The BCL-2 inhibitor venetoclax appears to have clinical activity in patients with acute myeloid leukemia when used in combination with either cytarabine or a…

Five important updates in prostate cancer

September 23, 2016
National Prostate Cancer Awareness Month, observed in September, is intended to educate men about disease risk factors, screening options and other matters related to…
More News Headlines »

Immunotherapy Updates 2015: FOCUS on NSCLC

This activity is supported by educational grants from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Eighty-five percent of lung cancers are non-small…
More »
Meeting News Coverage

VIDEO: Crenolanib, venetoclax demonstrate ‘very exciting’ results in AML

August 21, 2016
More »
At Issue: Breast Cancer Resource Center

At Issue: Breast Cancer Resource Center

CME Video

Optimizing the Management of Metastatic Melanoma: Clinical Insights for Selecting First-Line Therapy

This activity is supported by an independent educational grant from Merck & Co., Inc.

The incidence of melanoma is continuing to increase worldwide. In recent years, the treatment landscape for this…
More »
Current Issues
View the Current Issue
HemOnc Today